Table 2.

Univariate analysis of survival in patients with hepatocellular carcinoma (HCC) by Kaplan–Meier survival analysis and Cox regression analysis.

Characteristics	n	Median survival (months; 95% CI)	p(KP)	HR(%% CI)	p(Cox)
Age
≤54	47	25.000 (12.708–37.292)	0.503	0.838 (0.497–1.414)	0.508
>54	43	34.000 (19.009–48.991)
Sex
Male	81	29.000 (15.281–42.719)	0.625	0.798(0.318–1.999)	0.630
Female	9	29.000 (17.313–40.687)
Size
≤5	34	69.000 (43.457–73.534)	0.002	2.455(1.350–4.463)	0.003
>5	56	17.000 (7.839–26.161)
Histological grade
Well + Moderate	65	43.000 (10.169–75.831)	0.003	0.455 (0.264–0.786)	0.005
Poor	25	16.000 (7.892–24.108)
T classification
T1 + T2	46	69.000 (61.569–78.491)	0.000	2.641(1.532–4.555)	0.000
T3 + T4	44	16.000 (10.451–21.549)
N classification
Absent	88	29.000 (20.726–37.274)	0.249	2.236(0.538-9.288)	0.268
Present	2	13.000 (10.120–21.880)
Metastasis
Absent	88	29.000 (20.726–37.274)	0.065	3.459(0.833–	0.088
Present	2	2.000 (0.000–8.500)		14.374)
TNM stage
I + II	46	69.000 (61.569–78.491)	0.000	2.641(1.532–4.555)	0.000
III	44	16.000 (10.451–21.549)
CICs
Present	54	69.000 (55.656–80.068)	0.002	2.404(1.355–4.265)	0.003
Absent	36	16.000 (8.799–23.201)

Red values indicate significant differences between comparisons with less than 0.05.